The interaction between CCR5 and its ligand CCL5 supports tumor growth and invasion, and migration of MDSCs to the tumor site; tumor growth and invasiveness are suppressed by targeting the CCR5-CCL5 interaction [92,93,94]. The gene discussed is CCR5; the disease is neoplasm.